- Home
- SBGI vs GPCR Comparison
SBGI vs GPCR Comparison
Compare SBGI & GPCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SBGI
- GPCR
- Stock Information
- Founded
- SBGI 1986
- GPCR 2016
- Country
- SBGI United States
- GPCR United States
- Employees
- SBGI N/A
- GPCR N/A
- Industry
- SBGI Broadcasting
- GPCR
- Sector
- SBGI Industrials
- GPCR
- Exchange
- SBGI Nasdaq
- GPCR Nasdaq
- Market Cap
- SBGI 997.6M
- GPCR 1.1B
- IPO Year
- SBGI 1995
- GPCR 2023
- Fundamental
- Price
- SBGI $13.67
- GPCR $21.73
- Analyst Decision
- SBGI Buy
- GPCR Strong Buy
- Analyst Count
- SBGI 5
- GPCR 7
- Target Price
- SBGI $18.50
- GPCR $75.83
- AVG Volume (30 Days)
- SBGI 492.9K
- GPCR 823.8K
- Earning Date
- SBGI 08-06-2025
- GPCR 08-07-2025
- Dividend Yield
- SBGI 7.28%
- GPCR N/A
- EPS Growth
- SBGI N/A
- GPCR N/A
- EPS
- SBGI 1.97
- GPCR N/A
- Revenue
- SBGI $3,526,000,000.00
- GPCR N/A
- Revenue This Year
- SBGI N/A
- GPCR N/A
- Revenue Next Year
- SBGI $9.59
- GPCR N/A
- P/E Ratio
- SBGI $6.98
- GPCR N/A
- Revenue Growth
- SBGI 11.62
- GPCR N/A
- 52 Week Low
- SBGI $11.13
- GPCR $13.22
- 52 Week High
- SBGI $18.46
- GPCR $48.12
- Technical
- Relative Strength Index (RSI)
- SBGI 48.16
- GPCR 46.42
- Support Level
- SBGI $12.79
- GPCR $20.42
- Resistance Level
- SBGI $13.40
- GPCR $24.05
- Average True Range (ATR)
- SBGI 0.46
- GPCR 1.27
- MACD
- SBGI 0.03
- GPCR -0.04
- Stochastic Oscillator
- SBGI 69.10
- GPCR 38.62
About SBGI Sinclair Inc.
Sinclair Inc. is the owner-operator of the second largest portfolio of television stations in the United States, with 185 full power stations in 86 markets. Of the firm's roughly 600 channels, 150 are affiliated with the four national broadcasters—Fox, ABC, CBS, and NBC—with over 80 other channels aligned with The CW (Nexstar) and MyNetworkTV (Fox). Sinclair owns the Tennis Channel and stakes in Marquee Sports Network and YES Network, providing their content to pay-TV distributors.
About GPCR Structure Therapeutics Inc.
Structure Therapeutics Inc is a clinical-stage biopharmaceutical company developing novel oral small-molecule therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its differentiated technology platform leverages both structure-based drug discovery and expertise in computational chemistry to discover and develop small molecule therapeutics against G-protein coupled receptors (GPCRs). The group operates and manages its business as one reportable and operating segment, which is the business of research and development of medicines that target chronic diseases with unmet medical needs.